Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.
Sci Rep. 2022 Jan 13;12(1):4. doi: 10.1038/s41598-021-04229-0.
Sci Rep. 2022.
PMID: 35027594
Free PMC article.